Director/PDMR and PCA Shareholding

RNS Number : 4167B

Advanced Medical Solutions Grp PLC

03 April 2017

 

3 April 2017

            Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

            Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that it was notified on 29 March 2017 that Ingrid Meredith, the wife of Chris Meredith who is a Director and PDMR, had transferred 1,009,268 Ordinary Shares of 5p held in her name to Platform Securities Nominees Limited at nil consideration on 29 March 2017. The beneficial ownership of the shares remains unchanged.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name: Ingrid Meredith (the wife of Chris Meredith)
2.	Reason for the notification
a)	Position/status: PCA of a Director/PDMR
b)	Initial notification/Amendment: Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:   Advanced Medical Solutions Group plc
b)	LEI: 213800HJP6OWOSZI1L74
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594
b)	Nature of the transaction: ·        Transfer of 1,009,268 Ordinary Shares of 5p held by Ingrid Meredith in her own name into the name of Platform Securities Nominees Limited
c)	Price(s) and volume(s): Sale of shares: Price(s) Volume(s) Nil consideration 1,009,268
d)	Aggregated information: (Relates to those shares sold only) Aggregated volume: n/a Aggregated price: n/a
e)	Date of the transaction: 29/03/2017
f)	Place of the transaction: London Stock Exchange, AIM Market (XLON)

- End -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal^®, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand^® and RESORBA^®.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 600 employees.  For more information, please see www.admedsol.com.

 

END

 

 

DSHLLFISSAIVIID